TGFB1 and breast cancer: In transgenic mice bearing PyVmT-expressing mammary tumors, inhibition of TGF-β with the soluble fusion protein TβRII:Fc results in increased apoptosis of tumor cells and a reduction in both circulating tumor cells and lung metastases [49].